Literature DB >> 9593687

Caspase-mediated cleavage of the ubiquitin-protein ligase Nedd4 during apoptosis.

K F Harvey1, N L Harvey, J M Michael, G Parasivam, N Waterhouse, E S Alnemri, D Watters, S Kumar.   

Abstract

The onset of apoptosis is coupled to the proteolytic activation of a family of cysteine proteases, termed caspases. These proteases cleave their target proteins after an aspartate residue. Following caspase activation during apoptosis, a number of specific proteins have been shown to be cleaved. Here we show that Nedd4, a ubiquitin-protein ligase containing multiple WW domains and a calcium/lipid-binding domain, is also cleaved during apoptosis induced by a variety of stimuli including Fas-ligation, gamma-radiation, tumor necrosis factor-alpha, C-8 ceramide, and etoposide treatment. Extracts from apoptotic cells also generated cleavage patterns similar to that seen in vivo, and this cleavage was inhibited by an inhibitor of caspase-3-like proteases. In vitro, Nedd4 was cleaved by a number of caspases, including caspase-1, -3, -6, and -7. By site-directed mutagenesis, one of the in vitro caspase cleavage sites in mouse Nedd4 was mapped to a DQPD237 downward arrow sequence, which is conserved between mouse, rat, and human proteins. This is the first report demonstrating that an enzyme of the ubiquitin pathway is cleaved by caspases during apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593687     DOI: 10.1074/jbc.273.22.13524

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  E3 ubiquitin ligase Nedd4 is a key negative regulator for non-canonical inflammasome activation.

Authors:  Qingjun Liu; Shihui Zhang; Zhongjie Sun; Xiao Guo; Hong Zhou
Journal:  Cell Death Differ       Date:  2019-02-28       Impact factor: 15.828

2.  Caspase-mediated cleavage of p130cas in etoposide-induced apoptotic Rat-1 cells.

Authors:  S Kook; S R Shim; S J Choi; J Ahnn; J I Kim; S H Eom; Y K Jung; S G Paik; W K Song
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

3.  E3 ligase Nedd4 promotes axon branching by downregulating PTEN.

Authors:  Jovana Drinjakovic; Hosung Jung; Douglas S Campbell; Laure Strochlic; Asha Dwivedy; Christine E Holt
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

Review 4.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

5.  Targets of caspase-6 activity in human neurons and Alzheimer disease.

Authors:  Guy Klaiman; Tracy L Petzke; Jennifer Hammond; Andréa C Leblanc
Journal:  Mol Cell Proteomics       Date:  2008-05-16       Impact factor: 5.911

Review 6.  Nedd4 and Nedd4-2: closely related ubiquitin-protein ligases with distinct physiological functions.

Authors:  B Yang; S Kumar
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

7.  Apical membrane targeting of Nedd4 is mediated by an association of its C2 domain with annexin XIIIb.

Authors:  P J Plant; F Lafont; S Lecat; P Verkade; K Simons; D Rotin
Journal:  J Cell Biol       Date:  2000-06-26       Impact factor: 10.539

8.  SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.

Authors:  Jia Liu; Lixin Wan; Pengda Liu; Hiroyuki Inuzuka; Jiankang Liu; Zhiwei Wang; Wenyi Wei
Journal:  Oncotarget       Date:  2014-02-28

Review 9.  Many cuts to ruin: a comprehensive update of caspase substrates.

Authors:  U Fischer; R U Jänicke; K Schulze-Osthoff
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

10.  Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration.

Authors:  Libin Zhou; Kwangsik Nho; Maria G Haddad; Nicole Cherepacha; Agne Tubeleviciute-Aydin; Andy P Tsai; Andrew J Saykin; P Jesper Sjöström; Andrea C LeBlanc
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.